Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Elisabeth Fischer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Health Policy (Amsterdam, Netherlands)|August 8, 2012
A systematic review of coverage decision-making on health technologies-evidence from the real worldKatharina Elisabeth Fischer
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 7, 2014
Analysing coverage decision-making: opening Pandora's box?Katharina Elisabeth Fischer, Reiner Leidl
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 18, 2015
The diffusion of generics after patent expiry in GermanyKatharina Elisabeth Fischer, Tom Stargardt
International Journal of Environmental Research and Public Health|May 24, 2014
Funding decisions for newborn screening: a comparative review of 22 decision processes in EuropeKatharina Elisabeth Fischer, Wolf Henning Rogowski
Health Policy (Amsterdam, Netherlands)|September 16, 2016
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and AustraliaKatharina Elisabeth Fischer, Thomas Heisser, Tom Stargardt
Health Policy (Amsterdam, Netherlands)|November 8, 2016
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and DenmarkGisela Hostenkamp, Katharina Elisabeth Fischer, Knut Borch-Johnsen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2017
The impact of physician-level drug budgets on prescribing behaviorKatharina Elisabeth Fischer, Taika Koch, Karel Kostev, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Health Policy (Amsterdam, Netherlands)|August 8, 2012
A systematic review of coverage decision-making on health technologies-evidence from the real worldKatharina Elisabeth Fischer
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 7, 2014
Analysing coverage decision-making: opening Pandora's box?Katharina Elisabeth Fischer, Reiner Leidl
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 18, 2015
The diffusion of generics after patent expiry in GermanyKatharina Elisabeth Fischer, Tom Stargardt
International Journal of Environmental Research and Public Health|May 24, 2014
Funding decisions for newborn screening: a comparative review of 22 decision processes in EuropeKatharina Elisabeth Fischer, Wolf Henning Rogowski
Health Policy (Amsterdam, Netherlands)|September 16, 2016
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and AustraliaKatharina Elisabeth Fischer, Thomas Heisser, Tom Stargardt
Health Policy (Amsterdam, Netherlands)|November 8, 2016
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and DenmarkGisela Hostenkamp, Katharina Elisabeth Fischer, Knut Borch-Johnsen
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2017
The impact of physician-level drug budgets on prescribing behaviorKatharina Elisabeth Fischer, Taika Koch, Karel Kostev, et al.
Pageof 1